Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

被引:483
作者
Gordillo, V
del Amo, J
Soriano, V
González-Lahoz, J
机构
[1] Univ Complutense Madrid, Dept Res Methodol Educ, Madrid, Spain
[2] Hosp Carlos III, Psychol Unit, Madrid, Spain
[3] Subdirecc Gen Epidemiol & Informac Sanitarias, TB Res Unit, Madrid, Spain
[4] Inst Salud Carlos III, Hosp Carlos 3, Infect Dis Serv, Madrid, Spain
关键词
adherence; antiretroviral treatment; compliance; psychological factors; depression;
D O I
10.1097/00002030-199909100-00021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To assess the degree of compliance with antiretroviral therapy in HIV-infected patients, and identify which sociodemographic and psychological factors influence it, in order to develop strategies to improve adherence. Design and setting: Cross-sectional study in a reference HIV/AIDS institution located in Madrid, Spain. Patients and methods: A total of 366 HIV-infected patients who were on treatment with antiretroviral drugs were invited to complete a questionnaire which recorded sociodemographic data and psychological variables in relation to compliance with the prescribed medication. Clinical information was extracted from the hospital records. The Beck Depression inventory was used to assess depression, while adherence to treatment was evaluated using patient's self report and the pill count method. Results: A good adherence to antiretroviral therapy (> 90% consumption of the prescribed pills) was recorded in 211 (57.6%) patients. A good concordance for assessing adherence was found using the patient's self-report and the pill count method in a sub-group of patients. Predictors: of compliance in the univariate analysis were age, transmission category, level of studies, work situation, CD4 cell count level, depression and self-perceived social support. In the multivariate model, only age, transmission category, CD4 cell count level, depression, self-perceived social support, and an interaction between the last two variables predicted compliance to treatment; adherence to antiretroviral therapy was better among subjects aged 32-35 years [odds ratio (OR), 2.31; 95% confidence interval (CI), 1.21-4.40], in non-intravenous drug users (IVDUs) (OR, 2.05; 95% Cl, 1.28-3.29), subjects with CD4 cell counts from 200-499 x 10(6) cells/l at enrolment (OR, 2.78; 95%Cl, 1.40-5.51) and in subjects not depressed and with a self-perceived good social support (OR 1.86; 95% Cl, 0.98-3.53). Conclusions: Sociodemographic and psychological factors influence the degree of adherence to antiretroviral therapy. Overall,: IVDUs and younger individuals tend to have a poorer compliance, as well as subjects with depression and lack of self-perceived social support. An increased awareness of these factors by practitioners attending HIV-infected persons, recognizing and potentially treating some of them, should indirectly improve the effectiveness of antiretroviral therapy. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:1763 / 1769
页数:7
相关论文
共 45 条
[1]   The role of behavioral research in HIV/AIDS prevention [J].
Auerbach, JD .
CURRENT OPINION IN INFECTIOUS DISEASES, 1998, 11 (01) :3-7
[2]   COMPLIANCE IN CLINICAL-TRIALS [J].
BESCH, CL .
AIDS, 1995, 9 (01) :1-10
[3]  
Burak J. H., 1993, JAMA-J AM MED ASSOC, V270, P2563
[4]  
Carael M, 1996, AIDS, V10 Suppl A, pS181, DOI 10.1097/00002030-199601001-00025
[5]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[6]  
CHESNEY M, 1998, ANT AC M MONT TREMBL
[7]  
CONDE Y, 1975, REV PSICOL PSIQ MED, V4, P217
[8]   Dialogue: The core clinical skill [J].
Duffy, FD .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (02) :139-141
[9]   Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease [J].
Eldred, LJ ;
Wu, AW ;
Chaisson, RE ;
Moore, RD .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 (02) :117-125
[10]  
ERWIN J, 1998, INT ANTIVIRAL NEWS, V6, P12